Riskpilot← Back to searchSign inGet full accessSamedi Oy
OYDissolvedY-tunnus 2648431-4Tiilimäki 35-3Medical specialists activities · NACE 8622Est. 2014— employees
Revenue 2025
EUR 400K
+23% vs 2024
EBITDA margin
69.8%
-35% vs 2024
Equity ratio
98.6%
Financial strength
Net profit 2025
EUR 235K
+27% vs 2024
| Revenue | EUR 400K | +23% |
| EBITDA | EUR 279K | -35% |
| Net profit | EUR 235K | +27% |
| Total assets | EUR 1,2M | +16% |
| Equity | EUR 1,2M | +15% |
| Employees | — | — |
Legal name
Samedi Oy
Y-tunnus number
2648431-4
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
16. lokakuuta 2014
Share capital
EUR 2 500
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimiala on silmälääkäripalvelujen tuottaminen potilaille, alan koulutus- ja konsultointi sekä kustannustoiminta. Erilaisten terveydenhoitovälineiden ja -tarvikkeiden maahantuonti, tukku- ja vähittäiskauppa. Yhtiö voi omistaa, hallita ja vuokrata sekä välittää kiinteistöjä, liike- ja asuinhuoneistoja sekä kulkuneuvoja. Yhtiö voi harjoittaa arvopaperikauppaa.
Address
Tiilimäki 35-3
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 310 | 301 | 305 | 324 | 400 |
| Staff expenses | −48 | −2 | −3 | 4 | −10 |
| EBITDA | 185 | 209 | 214 | 429 | 279 |
| Depreciation & amort. | −51 | −26 | −30 | 11 | −14 |
| EBIT | 134 | 184 | 184 | 210 | 265 |
| Net financials | 3 | 14 | 48 | 18 | 10 |
| Profit before tax | 137 | 197 | 232 | 230 | 294 |
| Tax | 30 | 44 | 42 | 46 | −59 |
| Net profit | 107 | 153 | 189 | 184 | 235 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 707 | 796 | 928 | 1 028 | 1 193 |
| Equity | 694 | 792 | 916 | 1 027 | 1 177 |
| Long-term debt | — | — | 0 | — | — |
| Short-term debt | 13 | 4 | 12 | 1 | 16 |
| Total debt | 13 | 4 | 12 | 1 | 16 |
EBITDA margin
69.8%
This company
15.8%
Market median
+342% vs market
20212025
Equity ratio
98.6%
This company
38.2%
Market median
+158% vs market
20212025
Return on equity
19.9%
This company
18.4%
Market median
+8% vs market
20212025
Net profit margin
58.7%
This company
8.1%
Market median
+625% vs market
20212025
Asset turnover
0.33×
This company
1.12×
Market median
-71% vs market
20212025
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
JP Chief Executive Officer | Chief Executive Officer | 2014 |
JA | Audit | 2022 |
PR Deputy auditor | Deputy auditor | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2023 | |
| Chairperson | 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Samedi Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jari-Pekka Punkari | Chief Executive Officer | 0 companies |
| Jose Adam Juhani Kautonen | Audit | 0 companies |
| Petteri Raine Lagus | Deputy auditor | 0 companies |
| Patrik Mikael Punkari | Board of Directors | 0 companies |
| Liisa Johanna Sarmela | Chairperson | 0 companies |